Fluoxetine hydrochloride
Code | Size | Price |
---|
TAR-T0450L-25mg | 25mg | £109.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0450L-1mL | 1 mL * 10 mM (in DMSO) | £121.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0450L-50mg | 50mg | £122.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0450L-100mg | 100mg | £136.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0450L-200mg | 200mg | £189.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0450L-500mg | 500mg | £273.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Fluoxetine is the first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
CAS:
56296-78-7
Formula:
C17H18F3NO?HCl
Molecular Weight:
345.79
Pathway:
GPCR/G Protein; Neuroscience; Autophagy
Purity:
0.9966
SMILES:
Cl.CNCCC(Oc1ccc(cc1)C(F)(F)F)c1ccccc1
Target:
5-HT Receptor; Serotonin Transporter; Autophagy
References
1. Malberg JE, et al. Neuropsychopharmacology, 2003, 28(9), 1562-1571.
2. Kodama M, et al. Biol Psychiatry, 2004, 56(8), 570-580.
3. Wang JW, et al. J Neurosci, 2008, 28(6), 1374-1384.
4. Bymaster FP, et al. Psychopharmacology (Berl), 2002, 160(4), 353-361.
5. Zhang W, et al. Neuropsychopharmacology, 2000, 23(3), 250-262.
6. Su WJ, et al. Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance. J Neuroinflammation. 2017 Oct 30;14(1):210.
7. Gao T T, Wang Y, Liu L, et al. LIMK1/2 in the mPFC plays a role in chronic stress-induced depressive-like effects in mice[J]. International Journal of Neuropsychopharmacology. 2020, 23(12): 821-836.